Business
Press Release Mar 30 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis (PrEP).".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 30, 2023, titled \"Press Release on signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis (PrEP).\". View Attachment","length":425,"tagName":"div"}]